Glaucoma and cancer are debilitating diseases with increasing global prevalence and morbidity. However, current literature lacks a systematic consolidation of their relationships and interactions. This systematic review aims to (A) summarize the association between intraocular/non-ocular cancers and their treatments with the prevalence and etiology of glaucoma, (B) explore glaucoma as a risk factor for complications or poor prognosis for intraocular cancer, and (C) explore the management of glaucoma secondary to cancer therapies.
Methods
A systematic search was performed from inception to July 2025 across three databases with variants of ‘cancer’ and ‘glaucoma’ as search terms. Findings were narratively synthesized.
Results
Of 8,103 identified studies, 44 were included in this review. Eighteen studies reported increased glaucoma prevalence amongst intraocular and non-ocular cancer patients. Fifteen studies suggested increased risk of regional invasion, metastases, and high-risk histopathologies when intraocular cancers co-occurred with glaucoma. Corticosteroids in cancer therapy have been linked to intraocular pressure (IOP) elevation, while androgen deprivation therapy was associated with lowered glaucoma risk.
Conclusion
Given the relationship between glaucoma and intraocular/non-ocular cancers, strategies to monitor and manage glaucoma risk following cancer diagnosis and/or therapy may be considered. Glaucoma may be an early sign of complications in intraocular cancers.
ThamYCLiXWongTY, et al.Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology2014; 121: 2081–2090. DOI: 10.1016/j.ophtha.2014.05.013
2.
GBD. 2019 Blindness and vision impairment collaborators; vision loss expert group of the global burden of disease study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet Glob Health2021; 9: e144–e160. DOI: 10.1016/S2214-109X(20)30489-7
EjupiVGoriNGashiAM. Quality of life in cancer patients – A systematic review. Rom Med J2023; 70: 59–70. DOI: 10.37897/RMJ.2023.2.1
5.
KaurDGuptaASinghG. Perspectives on quality of life in glaucoma. J Curr Glaucoma Pract2012; 6: 9–12. DOI: 10.5005/jp-journals-10008-1101
6.
RadcliffeNMFingerPT. Eye cancer related glaucoma: current concepts. Review. Surv Ophthalmol2009; 54: 47–73. DOI: 10.1016/j.survophthal.2008.10.002
7.
AlsubaitAAldossaryWRashidM, et al.CYP1B1 Gene: implications in glaucoma and cancer. J Cancer2020; 11: 4652–4661. DOI: 10.7150/jca.42669
8.
Lo FaroVBhattacharyaAZhouW, et al.Novel ancestry-specific primary open-angle glaucoma loci and shared biology with vascular mechanisms and cell proliferation. Cell Rep Med2024; 5: 101430. DOI: 10.1016/j.xcrm.2024.101430
9.
StoicescuEAIancuRCCherecheanuAP, et al.Ocular adverse effects of anti-cancer chemotherapy. J Med Life2023; 16: 818–821. DOI: 10.25122/jml-2023-0041
10.
BindiganavileSHBhatNLeeAG, et al.Targeted cancer therapy and its ophthalmic Side effects: a review. J Immunother Precis Oncol2021; 4: 6–15. DOI: 10.36401/JIPO-20-21
11.
HamadaNAzizovaTVLittleMP. Glaucomagenesis following ionizing radiation exposure. Mutat Res Rev Mutat Res2019; 779: 36–44. DOI: 10.1016/j.mrrev.2019.01.001
12.
Kinaci-TasBAlderliestenTVerbraakFD, et al.Radiation-Induced retinopathy and optic neuropathy after radiation therapy for brain, head, and neck tumors: a systematic review. Cancers (Basel)2023; 15: 1999. DOI: 10.3390/cancers15071999
13.
ShenCJKrySFBuchsbaumJC, et al.Retinopathy, optic neuropathy, and cataract in childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review. Int J Radiat Oncol Biol Phys2024; 119: 431–445. DOI: 10.1016/j.ijrobp.2023.06.007
14.
EriksonKHeidenreichALabunskaV, et al.Evaluation of ocular and systemic endpoints after radiation of posterior uveal melanoma - A systematic review and meta-analysis. Heliyon2024; 10: e36468. DOI: 10.1016/j.heliyon.2024.e36468
15.
ZhengTWangDMiaoY, et al.Clinical efficacy and safety of proton radiotherapy for ocular conjunctival malignancies: a systematic review and meta-analysis. Front Public Health2025; 13: 1486988. DOI: 10.3389/fpubh.2025.1486988
16.
De Queiroz MendoncaCDe SouzaCJMartins-FilhoPR, et al.Steroid-induced ocular hypertensive response in children and adolescents with acute lymphoblastic leukemia and non-hodgkin lymphoma. Pediatr Blood Cancer2014; 61: 2083–2085. DOI: 10.1002/pbc.25070
17.
KonstantinidisLGroenewaldCCouplandSE, et al.Trans-scleral local resection of toxic choroidal melanoma after proton beam radiotherapy. Br J Ophthalmol2014; 98: 775–779. DOI: 10.1136/bjophthalmol-2013-304501
CorcoranNMMairFSNichollB, et al.Long-term conditions, multimorbidity and colorectal cancer risk in the UK biobank cohort. J Multimorb Comorb2022; 12: 26335565221110123. DOI: 10.1177/26335565221110123
20.
BujaraK. Necrotic malignant melanomas of the choroid and ciliary body. A clinicopathological and statistical study. Graefes Arch Clin Exp Ophthalmol1982; 219: 40–43. DOI: 10.1007/bf02159979
21.
ChantadaGLGonzalezAFandinoA, et al.Some clinical findings at presentation can predict high-risk pathology features in unilateral retinoblastoma. J Pediatr Hematol Oncol2009; 31: 325–359. DOI: 10.1097/MPH.0b013e3181923cc5
22.
LaurentVESamporCSolernouV, et al.Detection of minimally disseminated disease in the cerebrospinal fluid of children with high-risk retinoblastoma by reverse transcriptase-polymerase chain reaction for GD2 synthase mRNA. Eur J Cancer2013; 49: 2892–2899. DOI: 10.1016/j.ejca.2013.04.021
23.
BenekeAAWieseJDRootKT, et al.Lack of genetic association of non-melanoma skin cancer and pseudoexfoliative glaucoma. Ophthalmic Genet2024; 45: 623–625. DOI: 10.1080/13816810.2024.2390008
24.
UedaYSudaKKamedaT, et al.Risk factors for progression of primary open-angle glaucoma with lower normal intraocular pressure. Ophthalmic Res2024; 67: 184–191. DOI: 10.1159/000536314
25.
SugiyamaMTerashitaYHaraK, et al.Corticosteroid-induced glaucoma in pediatric patients with hematological malignancies. Pediatr Blood Cancer2019; 66: e27977. DOI: 10.1002/pbc.27977
26.
SawadaMTakachiTWatanabeK, et al.Steroid-induced ocular hypertensive response in pediatric patients with acute lymphoblastic leukemia. Jpn J Ophthalmol2023; 67: 396–401. DOI: 10.1007/s10384-023-01005-7
27.
QuYWangYXXuL, et al.Glaucoma-like optic neuropathy in patients with intracranial tumours. Acta Ophthalmol2011; 89: e428–e433. DOI: 10.1111/j.1755-3768.2011.02118.x
28.
AhnHKLeeHSParkJY, et al.Androgen deprivation therapy may reduce the risk of primary open-angle glaucoma in patients with prostate cancer: a nationwide population-based cohort study. Prostate Int2021; 9: 197–202. DOI: 10.1016/j.prnil.2021.05.001
29.
HaJSLeeHSParkJY, et al.Relationship between androgen deprivation therapy and normal-tension glaucoma in patients with prostate cancer: a nationwide cohort study. Yonsei Med J2022; 63: 908–914. DOI: 10.3349/ymj.2022.0122
30.
BarteFMMahasnehSAdams-HuetB, et al.Systemic illnesses in glaucoma: a possible link between glaucoma and breast cancer?Invest Ophthalmol Vis Sci2012; 53: 6386–6386.
31.
LeeCYYangSFChangYL, et al.The Presence of Ovarian Cancer and the Incidence of Subsequent Open-Angle Glaucoma: A Population-Based Cohort Study. Cancers (Basel)2024; 16: 1–10. DOI: 10.3390/cancers16162828
32.
KongAWAuASongW, et al.Intraocular pressure and cup-to-disc ratio asymmetry in diagnosing Iris melanoma. Clin Ophthalmol2024; 18: 2907–2915. DOI: 10.2147/OPTH.S440072
33.
NawaisehIAl-HussainiMAlhamwiA, et al.The impact of growth patterns of retinoblastoma (endophytic, exophytic, and mixed patterns). Turk Patoloji Derg2015; 31: 45–50. DOI: 10.5146/tjpath.2014.01278
34.
EagleRJ. High-risk features and tumor differentiation in retinoblastoma: a retrospective histopathologic study. Arch Pathol Lab Med2009; 133: 1203–1209. DOI: 10.5858/133.8.1203
35.
YoshizumiMOThomasJVSmithTR. Glaucoma-inducing mechanisms in eyes with retinoblastoma. Arch Ophthalmol1978; 96: 105–110. DOI: 10.1001/archopht.1978.03910050061015
36.
StadighAEPuskaPMKiveläTT. Incidence and risk factors for secondary glaucoma in eyes with uveal melanoma. Ophthalmol Glaucoma2023; 6: 29–41. DOI: 10.1016/j.ogla.2022.08.002
37.
HadjistilianouTGiglioniSMicheliL, et al.Analysis of aqueous humour proteins in patients with retinoblastoma. Clin Exp Ophthalmol2012; 40: e8–e15. DOI: 10.1111/j.1442-9071.2011.02711.x
38.
ShieldsCLShieldsJABaezK, et al.Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors. Cancer1994; 73: 692–698. DOI: 10.1002/1097-0142(19940201)73:3<692::aid-cncr2820730331>3.0.co;2-8
39.
KashyapSMeelRPushkerN, et al.Clinical predictors of high risk histopathology in retinoblastoma. Pediatr Blood Cancer2012; 58: 356–361. DOI: 10.1002/pbc.23239. .
40.
YaqoobNMansoorSZiaN, et al.Chemotherapy induced histopathological changes in retinoblastoma, assessment of high risk predictive factors & its correlation with comorbid conditions. Pak J Med Sci2022; 38: 362–368. DOI: 10.12669/pjms.38.ICON-2022.5786. .
41.
PrajantawanichKSanpakitKNarkbunnamN, et al.Clinical outcomes and prognosis of Thai retinoblastoma patients. Pediatr Int2021; 63: 671–677. DOI: 10.1111/ped.14498
42.
NegrettiGSUshakovaTYuriS, et al.Neovascular glaucoma as a predictor of retinoblastoma high-risk histopathology in an international multicentre study. Retina2025; 3: 565–573. DOI: 10.1097/iae.0000000000004340
43.
ShieldsCLDi NicolaMBekermanVP, et al.Iris melanoma outcomes based on the American joint committee on cancer classification (eighth edition) in 432 patients. Ophthalmology2018; 125: 913–923. DOI: 10.1016/j.ophtha.2017.11.040
44.
ColemanBaakVan Diest , et al.Prognostic factors following enucleation of 111 uveal melanomas. Br J OphthalmolNov 1993; 77: 688–692. DOI: 10.1136/bjo.77.11.688
45.
CassouxNCayetteSPlancherC, et al.Choroidal melanoma: does endoresection prevent neovascular glaucoma in patient treated with proton beam irradiation?Retina2013; 33: 1441–1447. DOI: 10.1097/IAE.0b013e31827f65c8
46.
SharkawiEOleszczukJDBerginC, et al.Baerveldt shunts in the treatment of glaucoma secondary to anterior uveal melanoma and proton beam radiotherapy. Br J Ophthalmol2012; 96: 1104–1107. DOI: 10.1136/bjophthalmol-2011-301420
47.
CaujolleJPMaschiCFretonA, et al.Treatment of neovascular glaucoma after proton therapy for uveal melanomas with ranibizumab injection: preliminary results. Ophthalmic Res2012; 47: 57–60. DOI: 10.1159/000328633
48.
MahdjoubiANajeanMLemaitreS, et al.Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy. Graefes Arch Clin Exp Ophthalmol2018; 256: 411–420. DOI: 10.1007/s00417-017-3834-3
49.
WändellPCarlssonACLjunggrenG. Systemic diseases and their association with open-angle glaucoma in the population of Stockholm. Int Ophthalmol2022; 42: 1481–1489. DOI: 10.1007/s10792-021-02137-w
50.
WhelanKFStrattonKKawashimaT, et al.Ocular late effects in childhood and adolescent cancer survivors: a report from the childhood cancer survivor study. Pediatr Blood Cancer2010; 54: 103–109. DOI: 10.1002/pbc.22277
51.
LuWYLinCWHsinCH, et al.Association of the nasopharyngeal carcinoma and the subsequent open glaucoma development: a nationwide cohort study. Int J Med Sci2023; 20: 702–708. DOI: 10.7150/ijms.80837
52.
JungYHanKNaKS, et al.Risk of cancer in patients with glaucoma: a nationwide population-based cohort study. Sci Rep2020; 10: 8170. DOI: 10.1038/s41598-020-65116-8
53.
HuangJJGeduldigJEJacobsEB, et al.Head and neck region dermatological ultraviolet-related cancers are associated with exfoliation syndrome in a clinic-based population. Ophthalmol Glaucoma2022; 5: 663–671. DOI: 10.1016/j.ogla.2022.04.002
54.
KangJHVoPhamTLadenF, et al.Cohort study of nonmelanoma skin cancer and the risk of exfoliation glaucoma. J Glaucoma2020; 29: 448–455. DOI: 10.1097/ijg.0000000000001496
55.
KarthikeyanATjoe-A-LongFKratzenbergL, et al.Analysis of intraocular pressure among patients with a history of cancer. Invest Ophthalmol Vis Sci2023; 64: 1385–1385.
56.
HewittAWSanfilippoPRingMA, et al.Mortality in primary open-angle glaucoma: ‘two cupped discs and a funeral’. Eye (Lond)2010; 24: 59–63. DOI: 10.1038/eye.2009.37
57.
YangPJLinCWLeeCY, et al.The Use of Androgen Deprivation Therapy for Prostate Cancer Lead to Similar Rate of Following Open Angle Glaucoma: A Population-Based Cohort Study. Cancers (Basel)2023; 15(. DOI: 10.3390/cancers15112915
58.
LinBLiD. The pivotal role of inflammatory factors in glaucoma: a systematic review. Front Immunol2025; 16: 1577200. DOI: 10.3389/fimmu.2025.1577200
59.
HernandezHMedina-OrtizWELuanT, et al.Crosstalk between transforming growth factor Beta-2 and toll-like receptor 4 in the trabecular meshwork. Invest Ophthalmol Vis Sci2017; 58: 1811–1823. DOI: 10.1167/iovs.16-21331
60.
PalsJMensinkHWBrosensE, et al.The effect of intraocular pressure-lowering medication on metastatic uveal melanomas. Cancers (Basel)2021; 13: 20211112. DOI: 10.3390/cancers13225657
61.
YadavS. Glaucoma Related to Ocular and Orbital Tumors. In: LanzaM (eds) Ocular Hypertension - The Knowns and Unknowns. 1st ed. London: IntechOpen, 2021.
62.
DavidorfFHMouserJGDerickRJ. Rapid improvement of rubeosis iridis from a single bevacizumab (avastin) injection. Retina2006; 26: 354–356. DOI: 10.1097/00006982-200603000-00017
63.
PozarowskaDPozarowskiP. The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy. Cent Eur J Immunol2016; 41: 311–316. DOI: 10.5114/ceji.2016.63132
64.
KotechaASprattAOgunbowaleL, et al.Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series. Arch Ophthalmol2011; 129: 145–150. DOI: 10.1001/archophthalmol.2010.350
65.
BakriSJSnyderMRReidJM, et al.Pharmacokinetics of intravitreal bevacizumab. Ophthalmology2007; 114: 855–859. DOI: 10.1016/j.ophtha.2007.01.017
66.
MłynarczykMFalkowskaMMicunZ, et al.Diet, oxidative stress, and blood Serum nutrients in Various types of glaucoma: a systematic review. Nutrients2022; 14: 1421. DOI: 10.3390/nu14071421
67.
DingDNXieLZShenY, et al.Insights into the role of oxidative stress in ovarian cancer. Oxid Med Cell Longev2021: 8388258. DOI: 10.1155/2021/8388258
68.
JassimAHFanYPappenhagenN, et al.Oxidative stress and hypoxia modify mitochondrial homeostasis during glaucoma. Antioxid Redox Signal2021; 35: 1341–1357. DOI: 10.1089/ars.2020.8180
69.
JelicMDMandicADMaricicSM, et al.Oxidative stress and its role in cancer. J Cancer Res Ther2021; 17: 22–28. DOI: 10.4103/jcrt.JCRT_862_16
70.
ChenZHanFDuY, et al.Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther2023; 8: 70. DOI:10.1038/s41392-023-01332-8
71.
MorganABFanYInmanDM. The ketogenic diet and hypoxia promote mitophagy in the context of glaucoma. Front Cell Neurosci2024; 18: 1409717. DOI:10.3389/fncel.2024.1409717
72.
YfantisAMylonisIChachamiG, et al.Transcriptional response to hypoxia: the role of HIF-1-associated co-regulators. Cells2023; 12: 798. DOI:10.3390/cells12050798
YeHFengYXiangW, et al.Ferroptosis contributes to retinal ganglion cell loss in GLAST knockout mouse model of normal tension glaucoma. Invest Ophthalmol Vis Sci2025; 66: 26. DOI:10.1167/iovs.66.5.26
75.
KasettiRBMaddineniPMillarJC, et al.Increased synthesis and deposition of extracellular matrix proteins leads to endoplasmic reticulum stress in the trabecular meshwork. Sci Rep2017; 7: 14951. DOI: 10.1038/s41598-017-14938-0
76.
KasettiRBMaddineniPPatelPD, et al.Transforming growth factor β2 signaling plays a key role in glucocorticoid-induced ocular hypertension. J Biol Chem2018; 293: 9854–9868. DOI: 10.1074/jbc.RA118.002540
77.
SherwinJCKokavecJThorntonSN. Hydration, fluid regulation and the eye: in health and disease. Clin Exp Ophthalmol2015; 43: 749–764. DOI: 10.1111/ceo.12546
78.
ParfittKMartindaleW (eds). Martindale: The Complete Drug Reference. 32nd ed. London, England: Pharmaceutical Press; 1999.
79.
JonasJAungTBourneRR, et al.Glaucoma. Lancet2017; 390: 2183–2193. DOI: 10.1016/S0140-6736(17)31469-1
80.
LeeJSLeeMHKimJH, et al.Cross sectional study among intraocular pressure, mean arterial blood pressure, and Serum testosterone according to the anthropometric obesity indices in Korean men. World J Mens Health2021; 39: 697–704. DOI: 10.5534/wjmh.200066
81.
NongpiurMEHeMGAmerasingheN, et al.Association between increased Lens vault and angle closure in Chinese Singaporeans. Invest Ophthalmol Vis Sci2010; 51: 5534.
82.
DumbrăveanuLCușnirVBobescuD. A review of neovascular glaucoma. Etiopathogenesis and treatment. Rom J Ophthalmol2021; 65: 315–329. DOI:10.22336/rjo.2021.66
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
